Vertex Pharmaceuticals Inc / Ma

TD PRIVATE CLIENT WEALTH LLC VRTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/27/2026

Shares

1,824

Value ($000)

815

Weight

0.0%

2019 Q4 - 2026 Q1 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/27/2026	815	0.0%	1,824	3/31/2026
2025 Q4	2/5/2026	836	0.0%	1,843	12/31/2025
2025 Q3	10/27/2025	701	0.0%	1,791	9/30/2025
2025 Q2	7/15/2025	1,833	0.0%	4,118	6/30/2025
2025 Q1	4/29/2025	3,018	0.1%	6,225	3/31/2025
2024 Q4	2/11/2025	2,504	0.1%	6,217	12/31/2024
2024 Q3	11/18/2024	6,366	0.2%	13,687	9/30/2024
2024 Q2	8/14/2024	4,778	0.2%	10,193	6/30/2024
2024 Q1	8/16/2024	5,357	0.2%	12,816	3/31/2024
2023 Q4	8/16/2024	5,648	0.2%	13,881	12/31/2023
2023 Q3	8/16/2024	5,250	0.2%	15,097	9/30/2023
2023 Q2	8/16/2024	5,659	0.2%	16,082	6/30/2023
2023 Q1	8/16/2024	5,405	0.2%	17,155	3/31/2023
2022 Q4	8/16/2024	4,364	0.2%	15,112	12/31/2022
2022 Q3	8/16/2024	4,419	0.2%	15,261	9/30/2022
2022 Q2	8/16/2024	4,442	0.2%	15,764	6/30/2022
2022 Q1	8/16/2024	2,874	0.1%	11,014	3/31/2022
2021 Q4	8/16/2024	2,351	0.1%	10,706	12/31/2021
2021 Q3	8/16/2024	2,060	0.1%	11,355	9/30/2021
2021 Q2	8/16/2024	1,460	0.1%	7,242	6/30/2021
2021 Q1	8/16/2024	156	0.0%	726	3/31/2021
2020 Q4	8/16/2024	1,999	0.1%	8,459	12/31/2020
2020 Q3	8/16/2024	2,836	0.2%	10,421	9/30/2020
2020 Q2	8/16/2024	3,006	0.2%	10,356	6/30/2020
2020 Q1	8/16/2024	185	0.0%	776	3/31/2020
2019 Q4	8/16/2024	144	0.0%	658	12/31/2019